Our Practices
- Asbestos
- Class Actions
- Commercial Litigation
- Defective Products
- Drug Injury
- Personal Injury
- Securities Fraud
- Toxic Exposure
- Whistleblower Claims
Current Investigations
General
Drug Injury
- Actos
- Accutane
- Fosamax
- GranuFlo/NaturaLyte
- Gadolinium
- Ocella, Yasmin, Yaz
- Pradaxa
- Sleeping Pills
- SSRIs
- Topamax
- Tylenol
- Zithromax/Z-pack
- Zocor/Simvastatin
Medical Devices
- Da Vinci Robot
- DePuy Hip Recall
- Mirena
- Stryker Recall
- Stryker Lawsuit
- Transvaginal Mesh
- Zimmer Hip Implant
Product Liability
- Aveeno Lawsuit
- Atlas Roofing Lawsuit
- Avon/Clarins Products
- AZEK Decking
- Chinese Drywall
- Chrysler Lock-Ups
- Demilec Insulation
- Electrolux Lawsuit
- Energy Drink Lawsuit
- Flushmate Systems
- Ford 5.4L Engine
- Ford & Mercury Transmissions
- Ford Mileage Claims
- GAF Decking
- Jeld-Wen Low E
- LP/ABTCO TrimBoard
- Norcold Lawsuit
- Pozzi and Jeld-Wen
- Remington Lawsuit
- TimberTech Decking
- Toyota Power Windows
- Trex Decking Lawsuit
Food
Pending Settlements
SEC Investigating Deal Between JPMorgan and Hedge Fund Magnetar
November 2nd, 2010

“Magnetar often purchased the riskiest portion of CDOs, enabling the banks to complete the deals. Magnetar also frequently bet against those same CDOs, using side bets. Magnetar’s purchases ultimately spawned at least $40 billion worth of risky CDOs in 2006 and 2007.”

